Stephen M. F. Jamieson

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer

Khine Nyein Myint, Riya Biswas, Yan Li et al. · Scientific Reports · 2019 · 261 citations · Full text

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Stephen M. F. Jamieson, Jack U. Flanagan, Sharada Kolekar et al. · Biochemical Journal · 2011 · 170 citations · Full text

Tumour Growth, Cancer Biology, Responsive Cell Lines +21

A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>

Kuzhuvelil B. Harikumar, Ajaikumar B. Kunnumakkara, Nobuo Ochi et al. · Molecular Cancer Therapeutics · 2010 · 170 citations · Full text

Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8-Hydroxyquinoline Anticancer Agents

Mario Kubanik, Hannah U. Holtkamp, Tilo Söhnel et al. · Organometallics · 2015 · 157 citations

Bioorganic Chemistry, 8-Hydroxyquinoline Organoruthenium Compounds, Chemoprevention Strategy +17

Synthesis and Biological Evaluation of Novel Analogues of the Pan Class I Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1<i>H</i>-benzimidazole (ZSTK474)

Gordon W. Rewcastle, Swarna A. Gamage, Jack U. Flanagan et al. · Journal of Medicinal Chemistry · 2011 · 103 citations · Full text